Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by ...
Panelists discuss how clinicians should interpret Clinical Dementia Rating-Sum of Boxes (CDR-SB) score changes by correlating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback